Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
189.2 INR | -1.66% |
|
+0.62% | +17.42% |
Jul. 02 | Marksans Pharma Gets UK Regulator's Nod for Two Products | MT |
May. 31 | Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.42% | 1.03B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- MARKSANS Stock
- News Marksans Pharma Limited
- Marksans Pharma Gets US FDA Nod for Pain Relief Drug